Crossmark

Investigation of Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions and performance of a rapid diagnostic test for identifying asymptomatic malaria infection in northern Ethiopia, 2015

Crossref DOI link: https://doi.org/10.1186/s12936-022-04097-7

Published Online: 2022-03-04

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leonard, Colleen M.

Assefa, Ashenafi

McCaffery, Jessica N.

Herman, Camelia

Plucinski, Mateusz

Sime, Heven

Mohammed, Hussein

Kebede, Amha

Solomon, Hiwot

Haile, Mebrahtom

Murphy, Matt

Hwang, Jimee

Rogier, Eric http://orcid.org/0000-0001-7375-8304
Funding

Funding for this research was provided by:

United States Agency for International Development
License Information

Text and Data Mining valid from 2022-03-04

Version of Record valid from 2022-03-04
More Information

Article History

Received: 14 October 2021

Accepted: 18 February 2022

First Online: 4 March 2022

Declarations

:

: The study protocol was approved by the Ethiopian Public Health Institute Scientific and Ethical Review Committee (SERC) and the ethical review committees of MACEPA/PATH and the CDC in Atlanta (#2015-244). The informed consent form was read to each participant in the appropriate local language and verbal informed consent was obtained. For children, parent’s consent was obtained before any blood sample was collected.

: All authors approved of this manuscript for publication.

: The authors declare no conflicts of interests.

Document is current

Any future updates will be listed below